These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30833770)

  • 1. CRISPR target prediction remains blunt tool for clinical applications.
    Hodgson J
    Nat Biotechnol; 2019 Mar; 37(3):204-205. PubMed ID: 30833770
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nanoblades: Pseudoviral shuttles for CRISPR-CAS9 delivery].
    Mangeot PE
    Virologie (Montrouge); 2019 Feb; 23(1):3-6. PubMed ID: 31131829
    [No Abstract]   [Full Text] [Related]  

  • 3. [Research progress in the third-generation genomic editing technology - CRISPR/Cas9].
    Zhou Y; Zong Y; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):713-6. PubMed ID: 27577230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CRISPR/Cas9 Genome Editing Revolution.
    Jiao R; Gao C
    J Genet Genomics; 2016 May; 43(5):227-8. PubMed ID: 27256542
    [No Abstract]   [Full Text] [Related]  

  • 5. EPO revokes Broad's CRISPR patent.
    Harrison C
    Nat Biotechnol; 2018 Mar; 36(3):209. PubMed ID: 29509734
    [No Abstract]   [Full Text] [Related]  

  • 6. The epigenome editors: How tools such as CRISPR offer new details about epigenetics.
    Willyard C
    Nat Med; 2017 Aug; 23(8):900-903. PubMed ID: 28777784
    [No Abstract]   [Full Text] [Related]  

  • 7. Plenary Symposia.
    In Vitro Cell Dev Biol Anim; 2018 Jun; 54(Suppl 1):2-5. PubMed ID: 29700742
    [No Abstract]   [Full Text] [Related]  

  • 8. Keynote Symposium.
    In Vitro Cell Dev Biol Anim; 2018 Jun; 54(Suppl 1):1. PubMed ID: 29700739
    [No Abstract]   [Full Text] [Related]  

  • 9. The New Frontiers in Cancer.
    Batista A
    Trends Cancer; 2016 Oct; 2(10):533. PubMed ID: 28741481
    [No Abstract]   [Full Text] [Related]  

  • 10. Focus on CRISPR tools and therapies.
    Nat Biotechnol; 2020 Jul; 38(7):765. PubMed ID: 32641851
    [No Abstract]   [Full Text] [Related]  

  • 11. CRISPR gene-editing tested in a person for the first time.
    Cyranoski D
    Nature; 2016 Nov; 539(7630):479. PubMed ID: 27882996
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology.
    Zhang D; Li Z; Li JF
    J Genet Genomics; 2016 May; 43(5):251-62. PubMed ID: 27165865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatments that made headlines in 2018.
    Chakradhar S
    Nat Med; 2018 Dec; 24(12):1785-1787. PubMed ID: 30523326
    [No Abstract]   [Full Text] [Related]  

  • 14. Clarifying the regulation of genome editing in Australia: situation for food.
    Kelly L
    Transgenic Res; 2019 Aug; 28(Suppl 2):161-164. PubMed ID: 31321699
    [No Abstract]   [Full Text] [Related]  

  • 15. Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos.
    Plaza Reyes A; Lanner F
    Development; 2017 Jan; 144(1):3-7. PubMed ID: 28049687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Transgenic Core Facility's Experience in Genome Editing Revolution.
    Yuan CL; Hu YC
    Adv Exp Med Biol; 2017; 1016():75-90. PubMed ID: 29130154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Academies relax stance on germline edits.
    Sheridan C
    Nat Biotechnol; 2017 Apr; 35(4):295-296. PubMed ID: 28398320
    [No Abstract]   [Full Text] [Related]  

  • 18. How genome editing could be used in the treatment of cardiovascular diseases.
    Musunuru K
    Per Med; 2018 Mar; 15(2):67-69. PubMed ID: 29714123
    [No Abstract]   [Full Text] [Related]  

  • 19. An overview of OECD activities related to modern techniques of biotechnology and genome editing : OECD conference on genome editing, June 2018.
    Kearns P
    Transgenic Res; 2019 Aug; 28(Suppl 2):41-44. PubMed ID: 31321681
    [No Abstract]   [Full Text] [Related]  

  • 20. Writing the Story of Gene Editing and CRISPR: An Interview with Kevin Davies, PhD.
    Flotte TR
    Hum Gene Ther; 2020 Dec; 31(23-24):1217-1220. PubMed ID: 33337270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.